BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv. 2011;4:195-205. [PMID: 21505166 DOI: 10.1161/circinterventions.110.959882] [Cited by in Crossref: 102] [Cited by in F6Publishing: 43] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Schunkert H, Colleran R, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA. Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). Eur Heart J 2020;41:3715-28. [PMID: 31511862 DOI: 10.1093/eurheartj/ehz594] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 31.0] [Reference Citation Analysis]
2 Karim Galougahi K, Ben-Yehuda O, Maehara A, Mintz GS, Stone GW, Ali ZA. "The scaffolding must be removed once the house is built"-spontaneous coronary artery dissection and the potential of bioresorbable scaffolds. J Thorac Dis 2016;8:E1398-403. [PMID: 27867640 DOI: 10.21037/jtd.2016.10.83] [Reference Citation Analysis]
3 Wong W, Lai CN, Cheng W, Tung L, Chang RC, Leung FK. Polymer–Metal Composite Healthcare Materials: From Nano to Device Scale. J Compos Sci 2022;6:218. [DOI: 10.3390/jcs6080218] [Reference Citation Analysis]
4 Ellwein L, Marks DS, Migrino RQ, Foley WD, Sherman S, LaDisa JF Jr. Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design. Catheter Cardiovasc Interv 2016;87:1244-55. [PMID: 27251470 DOI: 10.1002/ccd.26247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Blažević T, Heiss EH, Atanasov AG, Breuss JM, Dirsch VM, Uhrin P. Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases. Evid Based Complement Alternat Med 2015;2015:654098. [PMID: 26457112 DOI: 10.1155/2015/654098] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
6 Chan JW, Lewis DR, Petersen LK, Moghe PV, Uhrich KE. Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion. Biomaterials 2016;84:219-29. [PMID: 26828686 DOI: 10.1016/j.biomaterials.2015.12.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
7 Gurajala I, Gopinath R. Perioperative management of patient with intracoronary stent presenting for noncardiac surgery. Ann Card Anaesth 2016;19:122-31. [PMID: 26750683 DOI: 10.4103/0971-9784.173028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kushima H, Mori Y, Koshibu M, Hiromura M, Kohashi K, Terasaki M, Fukui T, Hirano T. The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis. Cardiovasc Diabetol 2017;16:122. [PMID: 28969637 DOI: 10.1186/s12933-017-0603-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
9 Tryfonos A, Green DJ, Dawson EA. Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention? Sports Med 2019;49:397-416. [PMID: 30719682 DOI: 10.1007/s40279-019-01055-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Abdelsalam M, Krishnan M, Banga S, Bachinsky WB. High-risk percutaneous coronary intervention in a patient with a single coronary artery presenting as STEMI and cardiogenic shock. BMJ Case Rep 2015;2015:bcr2015210345. [PMID: 26275407 DOI: 10.1136/bcr-2015-210345] [Reference Citation Analysis]
11 Seo HH, Kim SW, Lee CY, Lim KH, Lee J, Choi E, Lim S, Lee S, Hwang KC. A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells. Biol Res 2017;50:1. [PMID: 28100269 DOI: 10.1186/s40659-016-0106-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
12 Bogacki P, Kabłak-Ziembicka A, Bryniarski K, Wrotniak L, Ostrowska-Kaim E, Żmudka K, Przewłocki T. Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment. Postepy Kardiol Interwencyjnej 2016;12:303-13. [PMID: 27980543 DOI: 10.5114/aic.2016.63629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
13 Tang L, Pei H, Yang Y, Wang X, Wang T, Gao E, Li D, Yang Y, Yang D. The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway. Sci Rep 2016;6:29975. [PMID: 27453531 DOI: 10.1038/srep29975] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
14 Meier P, Indermuehle A, Pitt B, Traupe T, de Marchi SF, Crake T, Knapp G, Lansky AJ, Seiler C. Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis. BMC Med 2012;10:62. [PMID: 22720974 DOI: 10.1186/1741-7015-10-62] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
15 Alraies MC, Darmoch F, Tummala R, Waksman R. Diagnosis and management challenges of in-stent restenosis in coronary arteries. World J Cardiol 2017; 9(8): 640-651 [PMID: 28932353 DOI: 10.4330/wjc.v9.i8.640] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
16 Shirali AS, McDonald AI, Mack JJ, Iruela-Arispe ML. Reproducible Arterial Denudation Injury by Infrarenal Abdominal Aortic Clamping in a Murine Model. J Vis Exp 2016. [PMID: 27911412 DOI: 10.3791/54755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Kyaw H, Johal G, Gedela M, Barman N, Kini A, Sharma SK. Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis? Curr Cardiol Rep 2021;23:156. [PMID: 34599432 DOI: 10.1007/s11886-021-01582-4] [Reference Citation Analysis]
18 Masiero G, Mojoli M, Ueshima D, Tarantini G. Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease. J Thorac Dis 2017;9:S940-9. [PMID: 28894600 DOI: 10.21037/jtd.2017.06.36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
19 Li G, Qiao H, Lin H, Wang R, Chen F, Li S, Yang W, Yin L, Cen X, Zhang Y, Cheng X, Wang AY. Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review. Clin Neurol Neurosurg 2021;213:107065. [PMID: 34991058 DOI: 10.1016/j.clineuro.2021.107065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ismail MD, Ahmad WA, Leschke M, Waliszewski M, Boxberger M, Abidin IZ, Zuhdi AS. The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study. Springerplus 2016;5:1668. [PMID: 27730026 DOI: 10.1186/s40064-016-3350-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
21 Xiu WJ, Yang HT, Zheng YY, Ma YT, Xie X. Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis. Cardiol Res Pract 2018;2018:7658145. [PMID: 30155288 DOI: 10.1155/2018/7658145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Le V, Johnson CG, Lee JD, Baker AB. Murine model of femoral artery wire injury with implantation of a perivascular drug delivery patch. J Vis Exp 2015;:e52403. [PMID: 25742368 DOI: 10.3791/52403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Luca SR, Koh M, Qiu F, Alter DA, Bagai A, Bhatia RS, Czarnecki A, Goodman SG, Lau C, Wijeysundera HC, Ko DT. Stress testing after percutaneous coronary interventions: a population-based study. CMAJ Open 2017;5:E417-23. [PMID: 28559388 DOI: 10.9778/cmajo.20160159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 Kim H, Kim S, Baek SH, Kwon SM. Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration. Stem Cells Int 2016;2016:8340257. [PMID: 28090210 DOI: 10.1155/2016/8340257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
25 Gogas BD. Bioresorbable scaffolds for percutaneous coronary interventions. Glob Cardiol Sci Pract 2014;2014:409-27. [PMID: 25780795 DOI: 10.5339/gcsp.2014.55] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Chavarría J, Suárez de Lezo J, Ojeda S, Pan M, Segura J, Mazuelos F, Espejo S, López J, Romero M, Suárez de Lezo J. Restenosis After Everolimus-eluting Vascular Scaffolding. Angiographic and Optical Coherence Tomography Characterization. Rev Esp Cardiol (Engl Ed) 2017;70:543-50. [PMID: 28132761 DOI: 10.1016/j.rec.2016.10.002] [Reference Citation Analysis]
27 McDonald AI, Iruela-Arispe ML. Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury. Vascul Pharmacol 2015;72:9-15. [PMID: 26093336 DOI: 10.1016/j.vph.2015.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
28 Ikhapoh IA, Pelham CJ, Agrawal DK. Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells. Differentiation 2015;89:87-96. [PMID: 25913202 DOI: 10.1016/j.diff.2015.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
29 Shi X, Zhu P, Ling Y, Xue B, Liu J. Minimally invasive direct coronary artery bypass after percutaneous coronary intervention. J Card Surg 2022. [PMID: 35106840 DOI: 10.1111/jocs.16288] [Reference Citation Analysis]
30 Gao L, Wang YB, Jing J, Zhang M, Chen YD. Drug-eluting balloons versus new generation drug-eluting stents for the management of in-stent restenosis: an updated meta-analysis of randomized studies. J Geriatr Cardiol 2019;16:448-57. [PMID: 31308837 DOI: 10.11909/j.issn.1671-5411.2019.06.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
32 Suttorp MJ, Stella PR, Dens J, McKenzie JM, Park KS, Frambach P; SOLSTICE investigators. Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry). Neth Heart J 2015;23:124-9. [PMID: 25563495 DOI: 10.1007/s12471-014-0629-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
33 Marino BC, Nascimento GA, Rabelo W, Marino MA, Marino RL, Ribeiro AL. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes. Arq Bras Cardiol 2015;104:375-86. [PMID: 25651344 DOI: 10.5935/abc.20140216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Yang YX, Liu Y, Li CP, Lu PJ, Wang J, Gao J. Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis. J Interv Cardiol 2020;2020:8179849. [PMID: 32684867 DOI: 10.1155/2020/8179849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Testa L, Biondi Zoccai G, Tomai F, Ribichini F, Indolfi C, Tamburino C, Bartorelli A, Petronio AS, Bedogni F, De Carlo M. Italian Diffuse/Multivessel Disease ABSORB Prospective Registry (IT-DISAPPEARS). Study design and rationale. J Cardiovasc Med (Hagerstown) 2015;16:253-8. [PMID: 25469734 DOI: 10.2459/JCM.0000000000000219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
36 Tasic M, Sreckovic MJ, Jagic N, Miloradovic V, Nikolic D. Knuckle technique guided by intravascular ultrasound for in-stent restenosis occlusion treatment. Postepy Kardiol Interwencyjnej 2015;11:58-61. [PMID: 25848374 DOI: 10.5114/pwki.2015.49188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, Kini A, Sharma SK. Coronary In-Stent Restenosis: JACC State-of-the-Art Review. J Am Coll Cardiol 2022;80:348-72. [PMID: 35863852 DOI: 10.1016/j.jacc.2022.05.017] [Reference Citation Analysis]
38 Huang YH, Xu Q, Shen T, Li JK, Sheng JY, Shi HJ. Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model. Cardiol J 2019;26:283-91. [PMID: 29611172 DOI: 10.5603/CJ.a2018.0027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Zhao S, Tang Y, Cai H, Liu W, Zhang L, Chen D, Chen B. Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial. Evid Based Complement Alternat Med 2018;2018:8485472. [PMID: 29707035 DOI: 10.1155/2018/8485472] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
40 Chen Y, Murphy A, Scholz D, Geever LM, Lyons JG, Devine DM. Surface-modified halloysite nanotubes reinforced poly(lactic acid) for use in biodegradable coronary stents: Research Article. J Appl Polym Sci 2018;135:46521. [DOI: 10.1002/app.46521] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
41 Naik BI, Keeley EC, Gress DR, Zuo Z. Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention. Anesthesiology 2014;121:644-53. [PMID: 24950163 DOI: 10.1097/ALN.0000000000000350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Aoki J, Tanabe K. Mechanisms of drug-eluting stent restenosis. Cardiovasc Interv Ther 2021;36:23-9. [PMID: 33222019 DOI: 10.1007/s12928-020-00734-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
43 Tenekecioglu E, Farooq V, Bourantas CV, Silva RC, Onuma Y, Yılmaz M, Serruys PW. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovasc Disord 2016;16:38. [PMID: 26868826 DOI: 10.1186/s12872-016-0207-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
44 Otsuka Y, Murata T, Kono M, Imoto H, Koyama T, Nakamura K, Kadama S, Noguchi H, Saito T. Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy. Heart Vessels 2015;30:682-6. [PMID: 24906987 DOI: 10.1007/s00380-014-0528-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Varghese MJ, Bhatheja S, Baber U, Kezbor S, Chincholi A, Chamaria S, Buckstein M, Bakst R, Kini A, Sharma S. Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis. Circ Cardiovasc Interv. 2018;11:e006832. [PMID: 30354630 DOI: 10.1161/circinterventions.118.006832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
46 Rahinj GB, Chauhan HS, Sirivella ML, Satyanarayana MV, Ramanan L. Numerical Analysis for Non-Uniformity of Balloon-Expandable Stent Deployment Driven by Dogboning and Foreshortening. Cardiovasc Eng Technol 2021. [PMID: 34431035 DOI: 10.1007/s13239-021-00573-4] [Reference Citation Analysis]
47 Ijichi T, Nakazawa G, Torii S, Nagamatsu H, Yoshikawa A, Nakamura S, Souba J, Isobe A, Hagiwara H, Ikari Y. Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model. Int J Cardiol Heart Vasc 2021;34:100792. [PMID: 34036146 DOI: 10.1016/j.ijcha.2021.100792] [Reference Citation Analysis]
48 Zhang J, Ma Y, Wang Z, Li Y, Wang H, Wang Q. Association between Green Tea Consumption and In-Stent Restenosis in a Chinese Population after Percutaneous Coronary Intervention. J Nutr Sci Vitaminol 2022;68:120-6. [DOI: 10.3177/jnsv.68.120] [Reference Citation Analysis]
49 Fu Y, Zhang S, Du H, Li L, Wang C, Zheng G, Wang Y, Dong H, Jia H, Yu B. Impact of vessel curvature on neointimal healing after stent implantation as assessed by optical coherence tomography. Medicine (Baltimore) 2018;97:e0518. [PMID: 29668639 DOI: 10.1097/MD.0000000000010518] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 He J, Bao Q, Yan M, Liang J, Zhu Y, Wang C, Ai D. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease. Br J Pharmacol 2018;175:1354-61. [PMID: 28369744 DOI: 10.1111/bph.13806] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
51 Quam DJ, Gundert TJ, Ellwein L, Larkee CE, Hayden P, Migrino RQ, Otake H, LaDisa JF Jr. Immersive visualization for enhanced computational fluid dynamics analysis. J Biomech Eng 2015;137. [PMID: 25378201 DOI: 10.1115/1.4029017] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
52 Zhang Y, Bourantas CV, Farooq V, Muramatsu T, Diletti R, Onuma Y, Garcia-Garcia HM, Serruys PW. Bioresorbable scaffolds in the treatment of coronary artery disease. Med Devices (Auckl) 2013;6:37-48. [PMID: 23662091 DOI: 10.2147/MDER.S22547] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
53 Kandzari DE, Smits PC, Love MP, Ben-Yehuda O, Banai S, Robinson SD, Jonas M, Kornowski R, Bagur R, Iniguez A, Danenberg H, Feldman R, Jauhar R, Chandna H, Parikh M, Perlman GY, Balcells M, Markham P, Ozan MO, Genereux P, Edelman ER, Leon MB, Stone GW. Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). Circulation 2017;136:1304-14. [PMID: 28794001 DOI: 10.1161/CIRCULATIONAHA.117.028885] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
54 Guo S, Wu J, Ni M, Jia S, Zhang J, Zhou W, Liu X, Wang M, Zhang X. Comparative Efficacy of Danshen Class Injections for Treating Acute Coronary Syndrome: A Multidimensional Bayesian Network Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2020;11:1260. [PMID: 32982726 DOI: 10.3389/fphar.2020.01260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Liu PY, Lin WY, Lin LF, Lin CS, Lin WS, Cheng SM, Yang SP, Liou JT. Chest Pain with Normal Thallium-201 Myocardial Perfusion Image - Is It Really Normal? Acta Cardiol Sin 2016;32:328-36. [PMID: 27274174 DOI: 10.6515/acs20150517a] [Reference Citation Analysis]